However, the mechanism of IL-6 in B-CLL is complex, and its activity in neoplastic angiogenesis has been recognized via modulation of VEGF expression [37,38], but the action of IL-6 is possibly diverse, depending on the cellular form and the microenvironment. This evidence concerns the gene IL6 and B-cell chronic lymphocytic leukemia.